Tempest Therapeutics, Inc. Quarterly Current Ratio in % from Q1 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Tempest Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2013 to Q3 2024.
  • Tempest Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 265 %, a 7.52% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 265 -21.6 -7.52% Sep 30, 2024
Q2 2024 280 -7.6 -2.65% Jun 30, 2024
Q1 2024 289 -14.4 -4.74% Mar 31, 2024
Q4 2023 291 -10 -3.33% Dec 31, 2023
Q3 2023 287 -11.3 -3.79% Sep 30, 2023
Q2 2023 287 -90.7 -24% Jun 30, 2023
Q1 2023 304 -162 -34.8% Mar 31, 2023
Q4 2022 301 -183 -37.8% Dec 31, 2022
Q3 2022 298 -267 -47.3% Sep 30, 2022
Q2 2022 378 -116 -23.5% Jun 30, 2022
Q1 2022 466 +20.7 +4.66% Mar 31, 2022
Q4 2021 483 -87.3 -15.3% Dec 31, 2021
Q3 2021 565 -0.77 -0.14% Sep 30, 2021
Q2 2021 494 -55.4 -10.1% Jun 30, 2021
Q1 2021 445 -117 -20.8% Mar 31, 2021
Q4 2020 571 -35.1 -5.79% Dec 31, 2020
Q3 2020 566 -111 -16.3% Sep 30, 2020
Q2 2020 549 -246 -30.9% Jun 30, 2020
Q1 2020 562 -373 -39.9% Mar 31, 2020
Q4 2019 606 -441 -42.1% Dec 31, 2019
Q3 2019 677 -349 -34% Sep 30, 2019
Q2 2019 795 -130 -14% Jun 30, 2019
Q1 2019 935 +112 +13.7% Mar 31, 2019
Q4 2018 1.05K +234 +28.8% Dec 31, 2018
Q3 2018 1.03K +162 +18.8% Sep 30, 2018
Q2 2018 925 -13.8 -1.47% Jun 30, 2018
Q1 2018 823 -271 -24.8% Mar 31, 2018
Q4 2017 812 -278 -25.5% Dec 31, 2017
Q3 2017 863 -305 -26.1% Sep 30, 2017
Q2 2017 939 -294 -23.8% Jun 30, 2017
Q1 2017 1.09K -256 -19% Mar 31, 2017
Q4 2016 1.09K -625 -36.4% Dec 31, 2016
Q3 2016 1.17K -402 -25.6% Sep 30, 2016
Q2 2016 1.23K -172 -12.2% Jun 30, 2016
Q1 2016 1.35K +157 +13.2% Mar 31, 2016
Q4 2015 1.72K +762 +79.9% Dec 31, 2015
Q3 2015 1.57K +527 +50.4% Sep 30, 2015
Q2 2015 1.4K +144 +11.4% Jun 30, 2015
Q1 2015 1.19K -309 -20.6% Mar 31, 2015
Q4 2014 954 -829 -46.5% Dec 31, 2014
Q3 2014 1.04K -1.38K -57% Sep 30, 2014
Q2 2014 1.26K -1.05K -45.5% Jun 30, 2014
Q1 2014 1.5K -547 -26.7% Mar 31, 2014
Q4 2013 1.78K Dec 31, 2013
Q3 2013 2.43K Sep 30, 2013
Q2 2013 2.31K Jun 30, 2013
Q1 2013 2.05K Mar 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.